← FDA Drug Approvals (Drugs@FDA)

CARBOPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2006-02-15

Drug application

FDA Application #
ANDA077266
Application type
Abbreviated New Drug Application (Generic)
Brand name
CARBOPLATIN
Generic name
CARBOPLATIN
Active ingredients
CARBOPLATIN
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2006-02-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown